Murdoch-based regenerative medicine company Orthocell has posted its third consecutive quarter of record revenue, as it gears up for a final approval from the US FDA for its Remplir nerve product.
08/01/2025 - 12:56
Third quarter of record revenue for Orthocell
08/01/2025 - 12:56
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)